Cargando…
Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report
Herein, we present a case report of sintilimab treatment for a patient with ureteral cancer reoccurring after bladder cancer, and exploration of the mechanism of adverse reactions from the aspects of intestinal flora and immunity. We have reported a case of leukopenia in a patient with recurrent ure...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899141/ https://www.ncbi.nlm.nih.gov/pubmed/35280656 http://dx.doi.org/10.21037/tau-21-1146 |